These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 22658063)

  • 1. The role of nucleoside reverse transcriptase inhibitors usage in the incidence of hyperlactatemia and lactic acidosis in HIV/AIDS patients.
    Dragovic G; Jevtovic D
    Biomed Pharmacother; 2012 Jun; 66(4):308-11. PubMed ID: 22658063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. d4T plus ddI: warning for pregnant women.
    AIDS Treat News; 2001 Jan; (358):8. PubMed ID: 12173560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleoside reverse transcriptase inhibitor usage and the incidence of peripheral neuropathy in HIV/AIDS patients.
    Dragovic G; Jevtovic D
    Antivir Chem Chemother; 2003 Sep; 14(5):281-4. PubMed ID: 14694991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of acute pancreatitis and nucleoside reverse transcriptase inhibitors usage.
    Dragovic G; Milic N; Jevtovic DJ
    Int J STD AIDS; 2005 Jun; 16(6):427-9. PubMed ID: 15969777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleoside analogue-induced fatal lactic acidosis in two HIV-infected patients in Singapore.
    Hwang SW; Leo YS
    Singapore Med J; 2001 Jun; 42(6):247-51. PubMed ID: 11547960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for lactic acidosis in HIV-infected patients treated with nucleoside reverse-transcriptase inhibitors: a case-control study.
    Bonnet F; Bonarek M; Morlat P; Mercié P; Dupon M; Gemain MC; Malvy D; Bernard N; Pellegrin JL; Beylot J
    Clin Infect Dis; 2003 May; 36(10):1324-8. PubMed ID: 12746780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of switching to alternative nucleoside analogues following symptomatic hyperlactatemia and lactic acidosis.
    Lonergan JT; Barber RE; Mathews WC
    AIDS; 2003 Nov; 17(17):2495-9. PubMed ID: 14600521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa.
    Bolhaar MG; Karstaedt AS
    Clin Infect Dis; 2007 Jul; 45(2):254-60. PubMed ID: 17578788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for and outcome of hyperlactatemia in HIV-infected persons: is there a need for routine lactate monitoring?
    Imhof A; Ledergerber B; Günthard HF; Haupts S; Weber R;
    Clin Infect Dis; 2005 Sep; 41(5):721-8. PubMed ID: 16080096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study.
    Boubaker K; Flepp M; Sudre P; Furrer H; Haensel A; Hirschel B; Boggian K; Chave JP; Bernasconi E; Egger M; Opravil M; Rickenbach M; Francioli P; Telenti A
    Clin Infect Dis; 2001 Dec; 33(11):1931-7. PubMed ID: 11692306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactic acidosis and symptomatic hyperlactataemia in a randomized trial of first-line therapy in HIV-infected adults in South Africa.
    Dlamini J; Ledwaba L; Mokwena N; Mokhathi T; Orsega S; Tsoku M; Kowo H; Proschan M; Khabo P; Maja P; Hadigan C
    Antivir Ther; 2011; 16(4):605-9. PubMed ID: 21685549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactic acidosis and antiretroviral therapy: a case report and literature review.
    Marra A; Lewi D; Lanzoni V; Wey SB; Odashiro LN; Gomes PS; Silva E
    Braz J Infect Dis; 2000 Jun; 4(3):151-5. PubMed ID: 10934499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea.
    Moore RD; Wong WM; Keruly JC; McArthur JC
    AIDS; 2000 Feb; 14(3):273-8. PubMed ID: 10716503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of antiretroviral therapy in the incidence of pancreatitis in HIV-positive individuals in the EuroSIDA study.
    Smith CJ; Olsen CH; Mocroft A; Viard JP; Staszewski S; Panos G; Staub T; Blaxhult A; Vetter N; Lundgren JD
    AIDS; 2008 Jan; 22(1):47-56. PubMed ID: 18090391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New questions about an old combination--ddI + d4T.
    Proj Inf Perspect; 2003 Jan; (35):13-4. PubMed ID: 12647675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine.
    Walker UA; Bäuerle J; Laguno M; Murillas J; Mauss S; Schmutz G; Setzer B; Miquel R; Gatell JM; Mallolas J
    Hepatology; 2004 Feb; 39(2):311-7. PubMed ID: 14767983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of pancreatitis in HIV-infected patients receiving nucleoside reverse transcriptase inhibitor drugs.
    Moore RD; Keruly JC; Chaisson RE
    AIDS; 2001 Mar; 15(5):617-20. PubMed ID: 11316999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stavudine-induced hyperlactatemia/lactic acidosis at a tertiary communicable diseases clinic in South Africa.
    Hernández Pérez E; Dawood H
    J Int Assoc Physicians AIDS Care (Chic); 2010; 9(2):109-12. PubMed ID: 20484736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort Study.
    Rutschmann OT; Opravil M; Iten A; Malinverni R; Vernazza PL; Bucher H; Bernasconi E; Perrin LH; Yerly S; Hirschel B
    Antivir Ther; 1998; 3 Suppl 4():65-7. PubMed ID: 10723515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for mortality in symptomatic hyperlactatemia among HIV-infected patients receiving antiretroviral therapy in a resource-limited setting.
    Manosuthi W; Prasithsirikul W; Chumpathat N; Suntisuklappon B; Athichathanabadi C; Chimsuntorn S; Sungkanuparph S
    Int J Infect Dis; 2008 Nov; 12(6):582-6. PubMed ID: 18337140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.